Source Standards

1. Regulatory documents and drug labels from agencies such as the FDA, EMA, and MHRA for approval status and labelled indications.
2. ClinicalTrials.gov records and peer-reviewed trial publications for study design, populations, endpoints, and results.
3. Primary peer-reviewed research for molecular mechanisms and experimental findings.
4. Systematic reviews and consensus guidelines for established clinical context.
5. Curated databases including NCBI Gene, UniProt, ClinVar, COSMIC, and authoritative cancer-genomics portals for identifiers and annotations.

References should link to the most direct available source. A citation supports only the claim and context actually studied. Preprints, conference abstracts, press releases, and company announcements may describe emerging findings, but must not be presented as equivalent to peer-reviewed evidence or regulatory approval.

Biomedical evidence changes quickly. The update date indicates when a curated page last received a material editorial revision; it is not a guarantee that every referenced result is the newest available. Readers should confirm current labels and guidelines before using information in practice.